Ibritumomab Tiuxetan and Oxcarbazepine Extended-Release Tablets
Determining the interaction of Ibritumomab Tiuxetan and Oxcarbazepine Extended-Release Tablets and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: ibritumomab
Brand name: Y-90 Zevalin, In-111 Zevalin
Synonyms: Ibritumomab
Generic Name: oxcarbazepine
Brand name: Oxtellar XR, Trileptal
Synonyms: Oxcarbazepine, OXcarbazepine
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Ibritumomab Tiuxetan-Oxcarbazepine Oral Suspension
- Ibritumomab Tiuxetan-Oxcarbazepine Suspension
- Ibritumomab Tiuxetan-Oxcarbazepine Tablets
- Ibritumomab Tiuxetan-Oxecta
- Ibritumomab Tiuxetan-Oxilan
- Ibritumomab Tiuxetan-Oxipor VHC
- Oxcarbazepine Extended-Release Tablets-Ibrutinib
- Oxcarbazepine Extended-Release Tablets-Ibrutinib Capsules
- Oxcarbazepine Extended-Release Tablets-Ibrutinib Tablets
- Oxcarbazepine Extended-Release Tablets-Ibu
- Oxcarbazepine Extended-Release Tablets-IBU Tablets
- Oxcarbazepine Extended-Release Tablets-Ibu-2